SCHEMBL484780

SCHEMBL484780

CC(C)CN1CCC2(CC1)CCN(C(=O)c1ccc3c(c1)C(NC(=O)c1cccc(Cl)c1Cl)CC3)C2

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 9/20 0.44
CYP3A4 P08684 7/20 0.42
TAS1R3 Q7RTX0 4/20 0.42
TAS1R1 Q7RTX1 4/20 0.42
TAS1R2 Q8TE23 4/20 0.42
HSD17B10 Q99714 1/20 0.42
TSHR P16473 3/20 0.41
USP2 O75604 3/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 1/20 0.40
CYP1A2 P05177 3/20 0.38
SPTLC2 O15270 1/20 0.38
KCNA5 P22460 1/20 0.38
CYP2C9 P11712 1/20 0.37
HIF1A Q16665 1/20 0.37
P2RX7 Q99572 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484553 0.95 CYP2D6 (0.49) CYP2D6CYP3A4TAS1R3TAS1R1TAS1R2
SCHEMBL484857 0.93 TAS1R3 (0.41) CYP2D6CYP3A4TAS1R3TAS1R1TAS1R2
SCHEMBL484765 0.89 CYP2D6 (0.43) CYP2D6CYP3A4TAS1R3TAS1R1TAS1R2
SCHEMBL484330 0.88 CYP2D6 (0.49) CYP2D6CYP3A4HSD17B10TSHRUSP2
SCHEMBL2817716 0.87 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2ALDH1A1SPTLC2
SCHEMBL484832 0.87 ACHE (0.42) CYP2D6CYP3A4TAS1R3TAS1R1TAS1R2
SCHEMBL484646 0.87 TAS1R3 (0.43) CYP2D6CYP3A4TAS1R3TAS1R1TAS1R2
SCHEMBL484618 0.85 TSHR (0.46) CYP2D6CYP3A4HSD17B10TSHRUSP2
SCHEMBL484426 0.84 CYP2C9 (0.38) CYP2D6CYP3A4TAS1R3TAS1R1TAS1R2
SCHEMBL485266 0.84 P2RX7 (0.39) CYP2D6CYP3A4TAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885TAS1R3 339/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885TAS1R3 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.